Home › Funds › Trilogy Capital Inc. › SPMO
Trilogy Capital Inc. position in SPMO
INVESCO EXCH TRADED FD TR II
Trilogy Capital Inc. reported holding 327,977 shares of SPMO (INVESCO EXCH TRADED FD TR II) in its Q3 2026 13F filing — a position valued at US$49.7M, representing 1.93% of its reported portfolio and ranking #10 among its reported holdings. Trilogy Capital Inc. has disclosed SPMO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Trilogy Capital Inc.'s SPMO position evolved
Trilogy Capital Inc. first disclosed a stake in SPMO in Q3 2023 at 554,162 shares (US$31.7M). The position peaked in Q3 2026 at 327,977 shares, worth US$49.7M. Across 13 filings, Trilogy Capital Inc. increased the stake 4 time(s), trimmed it 7 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 327,977 shares valued at US$49.7M — an increase of 194,352 shares quarter over quarter.. Notable position changes include a 64% trim in Q2 2025 (shares rose 8% over the following quarter), a 145% increase in Q3 2026 (shares fell 13% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 554.16K | $31.74M | New |
| Q4 2023 | 592.70K | $38.82M | Add |
| Q1 2024 | 591.04K | $47.41M | Hold |
| Q2 2024 | 534.75K | $46.77M | Reduce |
| Q3 2024 | 415.38K | $37.65M | Reduce |
| Q4 2024 | 421.90K | $40.08M | Add |
| Q1 2025 | 380.92K | $35.25M | Reduce |
| Q2 2025 | 135.74K | $15.27M | Reduce |
| Q3 2025 | 149.64K | $18.12M | Add |
| Q4 2025 | 138.50K | $16.53M | Reduce |
| Q1 2026 | 136.64K | $15.32M | Reduce |
| Q2 2026 | 133.62K | $21.59M | Reduce |
| Q3 2026 | 327.98K | $49.71M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SPMO and 13F data
SPMO (INVESCO EXCH TRADED FD TR II) is a company whose sector is not yet classified in our data. 53 other funds we track also report a position in SPMO — the largest reported positions include LPL Financial LLC (US$1.24B), CWM, LLC (US$402.7M), VANTAGEPOINT INVESTMENT ADVISERS LLC (US$353.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SPMO
- LPL Financial LLC 8.21M sh · $1.24B · Q3 2026
- CWM, LLC 3.59M sh · $402.65M · Q1 2026
- VANTAGEPOINT INVESTMENT ADVISERS LLC 2.33M sh · $353.57M · Q3 2026
- Cambridge Investment Research Advisors, Inc. 1.39M sh · $210.09M · Q3 2026
- Performance Wealth Partners, LLC 924.97K sh · $140.21M · Q3 2026
- Private Advisor Group, LLC 792.82K sh · $120.18M · Q3 2026
- Storgate, LLC 763.92K sh · $115.80M · Q3 2026
- Equitable Holdings, Inc. 711.59K sh · $114.95M · Q2 2026
- PLANNING ALTERNATIVES LTD /ADV 715.81K sh · $108.50M · Q3 2026
- Redwood Investment Management, LLC 638.05K sh · $103.07M · Q2 2026
- Alpine Bank Wealth Management 498.03K sh · $75.49M · Q3 2026
- TD PRIVATE CLIENT WEALTH LLC 382.19K sh · $57.93M · Q3 2026
More on Trilogy Capital Inc.
FAQ
How long has Trilogy Capital Inc. held SPMO?
Trilogy Capital Inc. has disclosed SPMO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Trilogy Capital Inc.'s current position in SPMO?
As of Q3 2026, Trilogy Capital Inc. holds 327.98K shares of SPMO (INVESCO EXCH TRADED FD TR II), valued at $49.71M, representing 1.93% of its reported portfolio and ranking #10.
Has Trilogy Capital Inc. been buying or selling SPMO?
In the latest 13F filing (Q3 2026), Trilogy Capital Inc. increased its position in SPMO. The position peaked in Q3 2026 at 327.98K shares.
Which other funds hold SPMO?
Other major institutional holders of SPMO include LPL Financial LLC, CWM, LLC, VANTAGEPOINT INVESTMENT ADVISERS LLC, among 53 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.